# Amplify Commodity Trust: financial statements, quarterly

BDRY · NYSE · CIK 1610940 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/bdry.md) · [Financials](/companies/bdry/financials.md) · [Filings](/companies/bdry/filings.md) · [Insiders](/companies/bdry/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bdry/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [0.4](/filings/0001213900-24-098370.md) | [44.8](/filings/0001213900-25-014137.md) | [9.4](/filings/0001213900-25-043979.md) | [(8.1) d](/filings/0001213900-25-092470.md) | [(4.6)](/filings/0001213900-25-110548.md) | [(12.3)](/filings/0001213900-26-015020.md) | [5.9](/filings/0001213900-26-057535.md) | [(6.6) d](/filings/0001213900-26-103611.md) | [22.5](/filings/0001213900-25-110548.md) | [6.3](/filings/0001213900-26-015020.md) | [30.4](/filings/0001213900-26-057535.md) | [20.0 d](/filings/0001213900-26-103611.md) |

- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [68.3](/filings/0001213900-23-086962.md) | [63.5](/filings/0001213900-24-015372.md) | [66.2](/filings/0001213900-24-045347.md) | [42.5](/filings/0001213900-25-092470.md) | [28.1](/filings/0001213900-24-098370.md) | [35.4](/filings/0001213900-25-014137.md) | [64.2](/filings/0001213900-25-043979.md) | [68.6](/filings/0001213900-26-103611.md) | [44.0](/filings/0001213900-25-110548.md) | [36.5](/filings/0001213900-26-015020.md) | [103](/filings/0001213900-26-057535.md) | [52.7](/filings/0001213900-26-103611.md) |
| Total liabilities | $m | [0.3](/filings/0001213900-23-086962.md) | [0.4](/filings/0001213900-24-015372.md) | [0.7](/filings/0001213900-24-045347.md) | [1.3](/filings/0001213900-25-092470.md) | [0.8](/filings/0001213900-24-098370.md) | [3.1](/filings/0001213900-25-014137.md) | [1.1](/filings/0001213900-25-043979.md) | [1.4](/filings/0001213900-26-103611.md) | [3.7](/filings/0001213900-25-110548.md) | [1.3](/filings/0001213900-26-015020.md) | [2.6](/filings/0001213900-26-057535.md) | [7.6](/filings/0001213900-26-103611.md) |
| Shareholders' equity | $m | [68.0](/filings/0001213900-24-015372.md) | [63.1](/filings/0001213900-25-043979.md) | [65.5](/filings/0001213900-25-043979.md) | [41.2](/filings/0001213900-26-103611.md) | [27.3](/filings/0001213900-26-015020.md) | [32.4](/filings/0001213900-26-057535.md) | [63.1](/filings/0001213900-26-057535.md) | [67.1](/filings/0001213900-26-103611.md) | [40.3](/filings/0001213900-26-015020.md) | [35.2](/filings/0001213900-26-057535.md) | [100](/filings/0001213900-26-057535.md) | [45.1](/filings/0001213900-26-103611.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2021 (2020-12-31) | Q3 FY2021 (2021-03-31) | Q4 FY2021 (2021-06-30) | period not labelled (2022-09-30) | period not labelled (2022-12-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.8) d](/filings/0001213900-21-009542.md) | [21.4 d](/filings/0001213900-21-026432.md) | [(15.7) d](/filings/0001213900-21-047450.md) | [(27.8)](/filings/0001213900-23-086962.md) | [9.3 d](/filings/0001213900-24-015372.md) | [(15.4)](/filings/0001213900-24-098370.md) | [52.5 d](/filings/0001213900-25-014137.md) | [29.7 d](/filings/0001213900-25-043979.md) | [(1.4) d](/filings/0001213900-25-092470.md) | [(0.1)](/filings/0001213900-25-110548.md) | [(25.9) d](/filings/0001213900-26-015020.md) | [(13.6) d](/filings/0001213900-26-057535.md) |
| Share repurchases | $m | [7.7 d](/filings/0001213900-21-009542.md) | [23.0 d](/filings/0001213900-21-026432.md) | [39.6 d](/filings/0001213900-21-047450.md) | [12.6](/filings/0001213900-23-086962.md) | [13.8 d](/filings/0001213900-24-015372.md) | [11.4](/filings/0001213900-24-098370.md) | [50.2 d](/filings/0001213900-25-014137.md) | [36.0 d](/filings/0001213900-25-043979.md) | [25.1 d](/filings/0001213900-25-092470.md) | [10.5](/filings/0001213900-25-110548.md) | [4.8 d](/filings/0001213900-26-015020.md) | [2.4 d](/filings/0001213900-26-057535.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 9,200,040 at 2023-05-01, from the cover of the [10-Q filed 2023-05-15](/filings/0001213900-23-039662.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.